China Suppliers Factory Probiotics Premix for Blood Glucose Management & Clinical Research in Top Hospitals
Deposite: CCTCC M 2020833
Shelf life: 24 months
Storage conditions: Stored at -18℃or lower
Health Benefits
Functional Strains
Bifidobacterium animalis subsp. lactis F1-7
Bifidobacterium animalis subsp. lactis BA-C9
Lactiplantibacillus plantarum YZX21
Lactiplantibacillus plantarum F3-2
Lactiplantibacillus plantarum H-87
Lacticaseibacillus paracasei G15
Main Functions
Lower blood glucose
Reduce body weight
Adjuvant therapy
1 Clinical Study · 6 Invention Patents · 17 Literature Studies
- Achieved HbA1c <7.0 % within 90 days.
- Improved insulin resistance, with a significant reduction in HOMA-IR.
- Average weight reduction of 3.66 kg, with an average BMI decrease of 1.41.
Invention Patent: ZL202110019976.3 - A method for preparing and applying a combination of Bifidobacterium animalis subsp. lactis F1-7 and krill oil to improve atherosclerosis inflammation.
Tertiary Hospital · Clinical Evidence-Based Medicine
A Randomized, Double-Blind, Placebo-Controlled Feeding Trial of SugaRite ™ Premix Probiotics Powder for Improving Blood Glucose, Blood Lipids, and Body Mass Index in Patients with Type 2 Diabetes.
Research Institution: The Second Affiliated Hospital of Zhejiang University School of Medicine (a Grade III, Level A general hospital)
Total Sample Size: 60 patients with Type 2 Diabetes
Intervention Duration: 90 consecutive days of trial consumption
Primary Efficacy Endpoints: HbA1c, blood glucose, pancreatic islet function, insulin and C-peptide, blood lipid profile, body weight and BMI, etc.
Intervention Protocol: 2g, twice daily
Clinical Data 1: HbA1c reduced to below 7.0%, with a reduction of 0.73% and an attainment rate exceeding 80%.
Trial Notes: In the test group, the HbA1c attainment rate (<7.0%) reached 80.95%, with a significant absolute reduction of 0.73% (from a baseline of 7.14%). This reduction was 2.2 times greater than that observed in the control group, and the difference was statistically significant (P=0.0260).
This indicates that SugaRite ™ can effectively control HbA1c levels and may help prevent complications.
This indicates that SugaRite ™ can effectively control HbA1c levels and may help prevent complications.
Clinical Data 2: Improved insulin resistance and restored insulin sensitivity.
Trial Notes: While achieving blood glucose control, the required levels of insulin and C-peptide in the test group were significantly lower than those in the control group. This difference became particularly pronounced after 60 days of trial consumption. Coupled with the significant reduction in HOMA-IR (Homeostatic Model Assessment for Insulin Resistance), these findings collectively indicate that SugaRite ™ effectively enhances the body's insulin sensitivity and can help ameliorate insulin resistance.
Clinical Data 3: Significant reductions in body weight and BMI, contributing to weight management.
Trial Notes: The test group showed a significant reduction in body weight by 3.66 kg from baseline (from 72.55 kg to 68.77 kg), and a reduction in BMI by 1.41 (from 26.47 to 25.06). This improvement was nearly twice that observed in the control group, with the difference reaching statistical significance. It demonstrates that SugaRite ™ can promote weight loss and improvement in BMI.
Body Mass Index (BMI) and Body Weight: Weight reduction itself is one of the most effective methods for improving insulin resistance.
Body Mass Index (BMI) and Body Weight: Weight reduction itself is one of the most effective methods for improving insulin resistance.
Clinical Report
SugaRite ™ Premix Probiotics powder can regulate blood glucose, lower HbA1c, ameliorate insulin resistance, restore insulin sensitivity, and support weight management.
Frequently Asked Questions (FAQ)
What functional probiotic strains are used in this formulation?
This formula features six specific strains: Bifidobacterium animalis subsp. lactis F1-7, Bifidobacterium animalis subsp. lactis BA-C9, Lactiplantibacillus plantarum YZX21, Lactiplantibacillus plantarum F3-2, Lactiplantibacillus plantarum H-87, and Lacticaseibacillus paracasei G15.
What are the main health functions of SugaRite™ Premix Probiotics?
The primary clinical benefits include lowering blood glucose levels, reducing body weight, and acting as an effective adjuvant therapy for metabolic health management.
What clinical evidence supports the efficacy of this probiotic blend?
SugaRite™ is backed by rigorous scientific evidence, including 1 clinical trial (ChiCTR2400089551), 6 invention patents (such as ZL202110019976.3), and 17 literature studies.
How effective is SugaRite™ in managing HbA1c and insulin resistance?
In a 90-day clinical trial, over 80% of patients achieved an HbA1c level below 7.0%, showing an absolute reduction of 0.73%. The trial also noted significant improvements in insulin resistance and restored insulin sensitivity (HOMA-IR reduction).
Can this probiotic powder help with weight loss?
Yes. Clinical data demonstrated an average weight reduction of 3.66 kg and a BMI decrease of 1.41 over the 90-day trial period. Weight reduction is also directly linked to improving insulin resistance.
Where was the clinical trial conducted and what was the protocol?
The trial was a randomized, double-blind, placebo-controlled study conducted at The Second Affiliated Hospital of Zhejiang University School of Medicine. The study involved 60 Type 2 Diabetes patients who consumed 2g of the powder twice daily for 90 days.